FDA Approves Sunitinib for Adjuvant Treatment of RCC

FG_AUTHORS: Renal and Urology News

HTTP/1.1 200 OK Cache-Control: private Content-Type: text/html; charset=utf-8 Date: Thu, 16 Nov 2017 22:30:30 GMT From: VM-Web3-RUN Server: Microsoft-IIS/8.5 X-AspNet-Version: 4.0.30319 X-AspNetMvc-Version: 4.0 X-Powered-By: ASP.NET Content-Length: 122553 Connection: keep-alive

FDA Approves Sunitinib for Adjuvant Treatment of RCC - Renal and Urology News

Read more http://www.renalandurologynews.com/renal-cell-carcinoma-kidney-cancer-fda-approves-adjuvant-sunitinib-sutent/article/708025/

PUA Social Network

Twitter Facebook

Contact us

The Philippine Urological Association,Inc
3rd floor. PCS Bldg., 992 EDSA, Quezon City,
Metro Manila, PHILIPPINES 1105
View Map

+632-9256740 
+632-4544439
+63917-5244456

eMail us